Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection.
Saved in:
| Title: | Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection. |
|---|---|
| Authors: | Hughes SM; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA., Levy CN; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA., Calienes FL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Stekler JD; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Pandey U; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA., Vojtech L; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA., Berard AR; Departments of Obstetrics & Gynecology and Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada., Birse K; Departments of Obstetrics & Gynecology and Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA., Noël-Romas L; Departments of Obstetrics & Gynecology and Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA., Richardson B; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA., Golden JB; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA., Cartwright M; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA., Collier AC; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA., Stevens CE; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA., Curlin ME; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.; Department of Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, USA., Holtz TH; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand., Mugo N; Partners in Health Research and Development, Kenya Medical Research Institute, Thika, Kenya.; Center for Clinical Research (CCR), Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.; Department of Global Health, University of Washington, Seattle, WA, USA., Irungu E; Partners in Health Research and Development, Kenya Medical Research Institute, Thika, Kenya., Katabira E; Infectious Disease Institute, Makerere University, Kampala, Uganda., Muwonge T; Infectious Disease Institute, Makerere University, Kampala, Uganda., Lama JR; Asociación Civil Impacta Salud y Educación, Lima, Peru., Baeten JM; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Burgener A; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.; Departments of Obstetrics & Gynecology and Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.; Unit of Infectious Diseases, Department of Medicine Solna, Centre for Molecular Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden., Lingappa JR; Department of Pediatrics, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Mackelprang R; Department of Global Health, University of Washington, Seattle, WA, USA., McGowan I; Orion Biotechnology, Ottawa, ON, Canada.; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Cranston RD; Department of Infectious Diseases and Dermatology, University of Barcelona, Barcelona, Spain., Cameron MJ; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA., Hladik F; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. |
| Source: | Cell reports. Medicine [Cell Rep Med] 2020 Sep 22; Vol. 1 (6), pp. 100096. Date of Electronic Publication: 2020 Sep 22. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
